Canopy Growth (CGC) Interest & Investment Income (2019 - 2025)
Canopy Growth's (CGC) quarterly Interest & Investment Income came in at $1.0 million in Q4 2025, down 27.44% year-on-year from $1.4 million in Q4 2024, and down 29.78% quarter-over-quarter from $1.4 million in Q3 2025.
Canopy Growth (CGC) Interest & Investment Income (2019 - 2025) Analysis & Trends
Canopy Growth has disclosed Interest & Investment Income across 7 years of filings, most recently posting $1.0 million for Q4 2025.
- Interest & Investment Income for Q4 2025 came in at $1.0 million, down 27.44% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.0 million (down 84.36% YoY), and the FY2025 annual result was $170003.0, down 43.09% from the prior year.
- Interest & Investment Income came in at $1.0 million for Q4 2025 at Canopy Growth, down from $1.4 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $6.2 million in Q1 2023 to a low of -$296842.8 in Q1 2022.
- The 5-year median for Interest & Investment Income is $1.8 million (2021), against an average of $2.3 million.
- Across the five-year window, Interest & Investment Income plunged 116.41% in 2022 and surged 2183.21% in 2023, its largest moves.
- Canopy Growth's Interest & Investment Income stood at $1.2 million in 2021, then jumped by 315.55% to $5.2 million in 2022, then tumbled by 63.95% to $1.9 million in 2023, then dropped by 25.76% to $1.4 million in 2024, then retreated by 27.44% to $1.0 million in 2025.
- The last three Interest & Investment Income figures came in at $1.0 million (Q4 2025), $1.4 million (Q3 2025), and $762850.1 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Canopy Growth | 11.27 Mn | -137.42 Mn | 15.39 Mn | 1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.01 Mn |
| Sep 30, 2025 | 1.44 Mn |
| Jun 30, 2025 | 762,850.11 |
| Mar 31, 2025 | 1.67 Mn |
| Dec 31, 2024 | 1.39 Mn |
| Sep 30, 2024 | 1.77 Mn |
| Jun 30, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.78 Mn |
| Dec 31, 2023 | 1.87 Mn |
| Sep 30, 2023 | 2.58 Mn |
| Jun 30, 2023 | 5.83 Mn |
| Mar 31, 2023 | 6.18 Mn |
| Dec 31, 2022 | 5.19 Mn |
| Sep 30, 2022 | 3.78 Mn |
| Jun 30, 2022 | 3.10 Mn |
| Mar 31, 2022 | -296,842.75 |
| Dec 31, 2021 | 1.25 Mn |
| Sep 30, 2021 | 2.19 Mn |
| Jun 30, 2021 | 2.15 Mn |
| Mar 31, 2021 | 1.81 Mn |